Abstract
Abstract
Background: Application of reverse transcription quantitative real-time polymerase chain reaction is very well suited to reveal differences in gene expression between in vivo and in vitro produced embryos. Ultimately, this may lead to optimized equine assisted reproductive techniques. However, for a correct interpretation of the real-time PCR results, all data must be normalized, which is most reliably achieved by calculating the geometric mean of the most stable reference genes. In this study a set of reliable reference genes was identified for equine in vivo and fresh and frozen-thawed in vitro embryos.
Findings: The expression stability of 8 candidate reference genes (ACTB , GAPDH , H2A/I , HPRT1 , RPL32 , SDHA , TUBA4A , UBC ) was determined in 3 populations of equine blastocysts (fresh in vivo , fresh and frozen-thawed in vitro embryos). Application of geNorm indicated UBC , GAPDH , ACTB and HPRT1 as the most stable genes in the in vivo embryos and UBC , RPL32 , GAPDH and ACTB in both in vitro populations. When in vivo and in vitro embryos were combined, UBC , ACTB , RPL32 and GAPDH were found to be the most stable. SDHA and H2A/I appeared to be highly regulated.
Conclusions: Based on these results, the geometric mean of UBC , ACTB , RPL32 and GAPDH is to be recommended for accurate normalization of quantitative real-time PCR data in equine in vivo and in vitro produced blastocysts.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




